The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Laminin alpha 3 G 4/5 Domain as a Target for Carcinoma Therapy

Prof. Peter Marinkovich at Stanford University has discovered a method to prevent carcinoma progression through the use of antibodies that specifically target the laminin alpha 3 G 4/5 domain of cancer cells. Previously Dr. Marinkovich demonstrated that ...
more information »

Tunable cell signaling with engineered ligands

Researchers in Prof. Chris Garcia’s laboratory have developed a cancer therapeutic strategy using extracellular molecules that can modulate the cell signaling output of cytokine receptors or multimeric tyrosine kinase receptors. This technique uses exis...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.